EUVIMEDEUVIMED entdecken
Crossref

Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization

Jia Zhang, Meiwei Li, Xiaohang Zhou, Hailing Ni, Yiyue Huang, Xin Hu, Huangmo Lin, Xinyuan Cao, Xiao Han iD, Peng Sun iD

Diabetes · 2026

DOI: 10.2337/db26-0365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2026. Verfasst von Jia Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Key Laboratory of Molecular Targets and Interventions for Metabolic Diseases, Department of Biochemistry and Molecular Biology, Na…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Macrophages, Glucuronidase, Heparan Sulfate. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intraislet heparan sulfate (HS) barrier is essential for β-cell survival, yet its role in type 1 diabetes (T1D) remains incompletely understood. We investigated the expression pattern, pathogenic function, and therapeutic potential of the heparanase (HPSE)-HS axis in T1D by integrating single-cell RNA sequencing data sets from human and mouse islets and peripheral immune cells, together with genetic mouse models and pharmacological intervention. HPSE was selectively enriched in myeloid cells, particularly CD14++ classical monocytes from patients with T1D and NOD mice and was associated with activated proinflammatory and interferon signaling. In diabetic islets, increased HPSE expression was accompanied by marked degradation of the HS barrier. Myeloid-specific Hpse deficiency improved glucose tolerance, enhanced insulin secretion, and reduced infiltration of inducible nitric oxide synthase–positive macrophages and T cells, whereas islet-specific Hpse overexpression accelerated autoimmune diabetes and insulitis. Mechanistically, HPSE-mediated HS cleavage generated bioactive fragments that acted as costimulatory signals, amplifying IFN-γ–STAT1 signaling and promoting M1 macrophage polarization. Pharmacological inhibition of HPSE with muparfostat preserved the intraislet HS barrier and improved glucose homeostasis in nonobese T1D models. Collectively, these findings identify myeloid-derived HPSE as a key driver of T1D pathogenesis through dual effects on HS barrier disruption and inflammatory amplification and establish the HPSE-HS axis as an important regulator of the islet inflammatory microenvironment and a promising adjuvant therapeutic target for T1D. Article Highlights The role of the heparanase (HPSE)–heparan sulfate (HS) axis in type 1 diabetes remains incompletely defined. We examined whether myeloid-derived HPSE drives islet inflammation, how HS fragments influence macrophage polarization, and whether pharmacological inhibition is protective. We found that myeloid HPSE disrupts the intraislet HS barrier and that the resulting HS fragments potentiate interferon-γ–STAT1 signaling to promote proinflammatory macrophage polarization. Genetic or pharmacological inhibition of HPSE preserved islet integrity and ameliorated diabetes, identifying this pathway as a potential therapeutic target in type 1 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1MacrophagesGlucuronidaseHeparan SulfateMyeloid CellsAnimalsHeparanaseHumansMiceMice, Inbred NODFemaleIslets of LangerhansSignal TransductionInterferon-gamma

Substanzen

HeparanaseGlucuronidaseHeparan SulfateInterferon-gamma

Autor:innen und Institutionen

  • Jiangsu Provincial Key Laboratory of Molecular Targets and Interventions for Metabolic Diseases, Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, China.
  • National Demonstration Center for Experimental Basic Medical Education, Nanjing Medical University, Nanjing, China.
  • Department of Endocrinology, Third Affiliated Hospital with Nanjing Medical University, Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China.
  • The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China.

ORCID-Profile: Xiao Han, Peng Sun

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Li, M., Zhou, X., Ni, H., Huang, Y., Hu, X., Lin, H., Cao, X., Han, X., & Sun, P. (2026). Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization. Diabetes. https://doi.org/10.2337/db26-0365

Vancouver

Zhang J, Li M, Zhou X, Ni H, Huang Y, Hu X, et al. Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization. Diabetes. 2026. doi:10.2337/db26-0365

BibTeX
@article{Zhang2026,
  author = {Zhang, Jia and Li, Meiwei and Zhou, Xiaohang and Ni, Hailing and Huang, Yiyue and Hu, Xin and Lin, Huangmo and Cao, Xinyuan and Han, Xiao and Sun, Peng},
  title = {Myeloid-Specific Heparanase Aggravates Insulitis in Type 1 Diabetes via Heparan Sulfate Fragment-Dependent Amplification of Macrophage Polarization},
  journal = {Diabetes},
  year = {2026},
  doi = {10.2337/db26-0365}
}
Kostenlos starten →